Clinical trial
A Prospective Case Series Evaluating the Safety of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers
NCT02222454 is registered in ClinicalTrials.gov with KLOX Technologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Case Series Evaluating the Safety of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers
- Lead sponsor
- KLOX Technologies Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- Not reported
- Enrollment
- 3 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
pressure ulcers stage ii, pressure ulcers stage iii